These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10638)

  • 1. Aggregation of platelets and inert particles induced by thrombin.
    Chao FC; Tullis JL; Conneely GS; Lawler JW
    Thromb Haemost; 1976 Jun; 35(3):717-36. PubMed ID: 10638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet interaction with polymerizing fibrin.
    Niewiarowski S; Regoeczi E; Stewart GJ; Senyl AF; Mustard JF
    J Clin Invest; 1972 Mar; 51(3):685-99. PubMed ID: 4622107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo functions of thrombin-treated platelets.
    Reimers HJ; Kinlough-Rathbone RL; Cazenave JP; Senyi AF; Hirsh J; Packham MA; Mustard JF
    Thromb Haemost; 1976 Feb; 35(1):151-66. PubMed ID: 785686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the interactions of fibrinogen and soluble fibrin with washed rabbit platelets stimulated with ADP.
    Harfenist EJ; Packham MA; Mustard JF
    Thromb Haemost; 1985 Apr; 53(2):183-7. PubMed ID: 3927504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentration effects of platelets, fibrinogen and thrombin on platelet aggregation and fibrin clotting.
    Chao FC; Tullis JL; Kenney DM; Conneely GS; Doyle JR
    Thromb Diath Haemorrh; 1974 Sep; 32(1):216-31. PubMed ID: 4454041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
    Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unexpected effects of aurin tricarboxylic acid on human platelets.
    Kinlough-Rathbone RL; Packham MA
    Thromb Haemost; 1992 Aug; 68(2):189-93. PubMed ID: 1412166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing the deaggregation of human and rabbit platelets.
    Kinlough-Rathbone RL; Mustard JF; Perry DW; Dejana E; Cazenave JP; Packham MA; Harfenist EJ
    Thromb Haemost; 1983 Jun; 49(3):162-7. PubMed ID: 6308846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADP-mimicking platelet aggregation caused by rugosin E, an ellagitannin isolated from Rosa rugosa Thunb.
    Teng CM; Kang YF; Chang YL; Ko FN; Yang SC; Hsu FL
    Thromb Haemost; 1997 Mar; 77(3):555-61. PubMed ID: 9066010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of thrombin-degranulated human platelets: development of a method that does not use proteolytic enzymes for deaggregation.
    Kinlough-Rathbone RL; Packham MA; Guccione MA; Richardson M; Harfenist EJ; Mustard JF
    Thromb Haemost; 1991 Apr; 65(4):403-10. PubMed ID: 2057923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of stability of aggregates after thrombin-induced reaggregation of thrombin-degranulated platelets.
    Kinlough-Rathbone RL; Packham MA; Perry DW; Mustard JF; Cattaneo M
    Thromb Haemost; 1992 Apr; 67(4):453-7. PubMed ID: 1631794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
    Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
    Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ticlopidine selectively inhibits human platelet responses to adenosine diphosphate.
    Cattaneo M; Akkawat B; Lecchi A; Cimminiello C; Capitanio AM; Mannucci PM
    Thromb Haemost; 1991 Dec; 66(6):694-9. PubMed ID: 1665598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro interaction between cultured cells and human blood platelets.
    Holme R; Oftebro R; Hovig T
    Thromb Haemost; 1978 Aug; 40(1):89-102. PubMed ID: 725854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adhesion of platelets to purified solid-phase von Willebrand factor: effects of wall shear rate, ADP, thrombin, and ristocetin.
    Olson JD; Zaleski A; Herrmann D; Flood PA
    J Lab Clin Med; 1989 Jul; 114(1):6-18. PubMed ID: 2786916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmin inhibition of thrombin-induced platelet aggregation.
    Miller JL; Katz AJ; Feinstein MB
    Thromb Diath Haemorrh; 1975 Apr; 33(2):286-309. PubMed ID: 124475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet interaction with a pancreatic ascites tumor.
    Hamilton J; Subbarao V; Granack K; Ts'ao C
    Am J Pathol; 1986 Jan; 122(1):160-8. PubMed ID: 3510553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of ADP-induced platelet aggregation prevent fibrinogen binding to rabbit platelets and cause rapid deaggregation and dissociation of bound fibrinogen.
    Harfenist EJ; Packham MA; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1981 May; 97(5):680-8. PubMed ID: 6783712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-platelet recognition during aggregation: distinct mechanisms determined by the release reaction.
    Agam G; Livne A
    Thromb Haemost; 1984 Apr; 51(2):145-9. PubMed ID: 6740546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.